Today more than ever healthcare providers and independent sellers and servicers of used medical imaging equipment are facing pressures from the lack of adequate cooperation in providing service access information. More than ever, there is a need for IAMERS’ advocacy to ensure stake holders are aware of the safe and successful roles of independent sellers and servicers. As the U.S. FDA noted in its 2018 Report on Safety and Effectiveness of Servicing of Medical Devices, “the objective evidence indicates that many OEMs and third-party entities provide high quality, safe, and effective servicing of medical devices.” 

Importantly, the FDA also noted “the continued availability of third party entities to service and repair medical devices is critical to the functioning of the U.S. healthcare system.” With the ongoing pandemic and other regional challenges, similar expressions of the need for choices have been made in the EU and indeed worldwide.

  IAMERS’ commitment, world-wide, is to ensure healthcare providers have choices. Independent service providers are committed to  ‘best practices’ for patient safety. Recognizing that patient safety requires cooperation (not conflict) IAMERS brings the ‘Right to Choose’ message to legislative, regulatory and standards forums in the U.S., E.U., Asia and beyond. But ongoing business survival challenges demand your active support more than ever before. Without IAMERS’ advocacy, the message of safe and effective independent sales and service could be muted.

Learn More about IAMERS and join with us in our efforts to ensure cooperation.

The International Association of Medical Equipment Remarketers and Servicers, better known as IAMERS. Our membership is worldwide and represents companies ranging from the largest OEMs to smaller highly specialized companies that sell, service and finance pre-owned medical imaging devices.

For almost 27-years our members have installed, remanufactured or refurbished medical imaging devices for facilities around the world. Our members provide high clinical value equipment to the medical service provider at a fraction of the new equipment price.